Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

ARSYNL Rx vs Invigor Medical

By GLP-1 ScorecardUpdated

ARSYNL RxFactor scores not reassessed.
Site position #381

Lower score

Invigor MedicalFactor scores not reassessed.
Site position #9

Higher score

Score comparison

Invigor Medical has the higher recorded score — 86.1/100 to 59.1/100.

Invigor Medical grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Now Try Invigor, this platform advertises class-based GLP-1 plans; confirm your medicine and supply before accepting its starting price.

Before you choose

Before comparing the headline prices, the ARSYNL Rx review and the Invigor Medical review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, ARSYNL Rx vs Ondra Health and Ascend Medical vs Invigor Medical compare each of them with another graded program, and the list of alternatives to ARSYNL Rx ranks the programs closest to ARSYNL Rx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the Belle Health review covers one graded close to these two, at 73.8/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueInvigor Medical +41
43
84
Dose & formulationInvigor Medical +20
64
84
Clinical oversightInvigor Medical +10
78
88
Labs & monitoringInvigor Medical +33
53
86
FulfillmentInvigor Medical +25
63
88
Contract termsInvigor Medical +35
55
90
ARSYNL Rx · top barInvigor Medical · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricARSYNL RxInvigor Medical
WeighScore59.1/10086.1/100
GradeCB
Site position#381#9
Semaglutide$219/mo (advertised, compounded; confirm selected quote)Medication-specific quote unconfirmed; public GLP-1 treatment starts at $225.
Tirzepatide$269/mo (advertised, compounded with B12; confirm selected quote)Medication-specific quote unconfirmed; public GLP-1 + GIP treatment starts at $350/month.
CoverageAdvertises nationwide service; confirm selected treatment availabilityU.S. only; confirm medication-specific state availability
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
ARSYNL Rx

Site position #381 · C

Factor scores not reassessed.

Strengths

  • Publishes separate injection product pages
  • Advertises clinician review and shipping
  • Publishes the carrier handoff point in its returns policy

What to consider

  • The general program starting price does not identify the selected product
  • Paid orders are final after carrier handoff
  • Selected treatment availability and renewal need confirmation
Invigor Medical

Site position #9 · B

Factor scores not reassessed.

Strengths

  • Consultation, medication and supplies advertised together
  • Ordinary and microdose treatment listings are separately presented
  • Clinical policy describes virtual consultation and relevant testing when needed

What to consider

  • Current medication-specific dose and supply quote is unconfirmed
  • Cancel new orders before the prescription enters the practitioner's queue
  • Subscriptions need seven days’ notice before renewal processing; charges may occur early
  • No universal GLP-1 lab panel, frequency or separate testing price published

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard